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daytime and nocturnal hypoglycaemia. Non-linear regression curves were fitted 
to the total disutility of different frequencies of hypoglycaemic events. A weight-
ing scheme was used to allow each data point (one event quarterly, one monthly, 
one weekly or three weekly) to reflect the range of hypoglycaemic frequencies the 
data point represented. Non-parametric bootstrapping was applied to character-
ise the uncertainty of the marginal disutility. Results: Power function regres-
sion curves were estimated at Ud= 0.0141x0.3393 and Ud= 0.0221x0.3277, where Ud is 
disutility and x is the annual hypoglycaemic event rate, for non-severe day-
time and non-severe nocturnal events. An increase from 0 to 1 hypoglycaemic 
events per year, produced a utility decrease of 0.0141 for non-severe daytime, 
and 0.0221 for non-severe nocturnal, whereas an increase of one hypoglycaemic 
event per year for a patient who experiences 25 hypoglycaemic events per year 
produces a marginal impact of 0.0006 and 0.0008 for non-severe daytime and 
non-severe nocturnal, respectively. ConClusions: If patient-level data are avail-
able, non-linear functions estimated with TTO data might improve the precision 
of the measured impact of hypoglycaemic events. The results seen here illustrate 
diminishing marginal disutility with increasing numbers of hypoglycaemic events. 
This fits with the phenomenon of “first being worst” with regards to hypogly-
caemia.
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objeCtives: To compare the health related quality of life (HRQoL) in Polish patients 
with type 2 diabetes (T2D) and in matched sample from the general popula-
tion. Methods: Data on HRQoL came from two non-interventional studies: pro-
spective study of patients with T2D and EQ-5D Polish general population norms 
study. Analysis of HRQoL was conducted in four separate age groups: 32–44, 45–54, 
55–64 and above 65 years. We analyzed: an subjective and objective assessment 
of HRQoL (EQ VAS and EQ-5D index) and the presence of restrictions within five 
dimensions of the EQ-5D descriptive part. Results: A total of 274 patients with T2D 
and 214 representatives from population norms study, were included. EQ VAS was 
systematically lower in diabetic patients compared to the general population, and 
decreased with age (68.2 vs 83.9, 62.4 vs 79.2; 54.9 vs 78.1, 50.2 vs. 69.8 in consecutive 
age groups). A similar relationship was observed with EQ-5D index. The largest mean 
differences were observed among subjects aged 55-64 years (EQ VAS: 23.2, EQ-5D 
index: 0.085). In three domains: self-care, usual activities and anxiety/depression, 
patients with diabetes above 45 years of age, reported significantly more problems 
than respondents from the general population. ConClusions: Both subjective 
and objective HRQoL in patients with T2D is lower than in respondents of similar 
age from the general population. Compared with type 2 diabetic populations from 
other countries, Polish patients characterize by a relatively high HRQoL objective 
assessment and very low subjective assessment.
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objeCtives: The impact of Type 2 diabetes mellitus (T2DM) on health related quality 
of life (HRQL) is complex due to the burden of disease, lifelong treatment require-
ments and comorbidities. This study aimed to capture UK societal utility values for 
health states associated with T2DM and treatment-related adverse events (AEs) to 
assess the burden of the disease and common AEs. Methods: Nine health state 
descriptions were developed (from a literature review and patient and clinician 
qualitative input) depicting the burden associated with T2DM and treatment related 
AEs. These were mild/moderate urinary tract infection (UTI); severe UTI; mycotic 
infection; moderate hypoglycaemic events; severe hypoglycaemic events; fear of 
hypoglycaemia; gastrointestinal symptoms; and hypovolaemic events. Members 
of the UK general public (n= 100) valued these states using the time trade-off (TTO) 
methodology to elicit utility values (between 0= dead, 1= full health). Regression 
analysis was conducted to understand influence of age and gender. Results: All 
treatment-related AEs were found to have a significant effect on utility. From the 
T2DM baseline state (0.92), the experience of AEs was associated with the follow-
ing disutility: T2DM with hypovolaemic events (0.08); T2DM with mild/ moderate 
UTIs (0.09); T2DM with moderate hypoglycaemic events (0.11); T2DM with severe 
hypoglycaemic events (0.15); T2DM with fear of hypoglycaemia (0.15); T2DM with 
severe UTIs (0.19); T2DM with GI symptoms (0.24); andT2DM with mycotic infection 
(0.25); Males consistently scored the states with significantly lower utility values, but 
no significant age effects emerged. ConClusions: Findings suggest that adverse 
events in T2DM can be a burden for some individuals. The study indicates the poten-
tial importance of including information regarding AEs in economic evaluations. 
Although some states were rated severely in terms of utility, in reality, many of 
these only last a few days, therefore having a minimal quality adjusted life year 
(QALY) impact.
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cohorts. Daily number of prescribed tablets whatever the therapeutic classes is 
significantly higher in the free cohort (4.4 per day vs. 3.1, p< 0.01). At the end of the 
first treatment year, significantly more patients of the fixed cohort are still treated 
by the same association regardless daily dosages or potential add-on treatments 
(85% vs. 72%, p< 0.0001); moreover MPR is the same in both free and fixed cohort 
(64% and 66% without statistical difference) while PDC is significantly higher in 
the fixed cohort (60% vs. 54%, P< 0.0001). ConClusions: Patients treated by fixed 
antidiabetic treatments associations seem to be more persistent than these 
treated by free ones at the end of the first year of treatment. These results will be 
consolidated soon by comparing two similar sub-cohorts with the same medical 
profile.
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objeCtives: Low adherence to medications in chronic diseases is a well docu-
mented problem that diminishes drug actions. Understanding the factors that 
can impact adherence is a priority in order to improve it. Diabetes adherence can 
be influenced by the complexity of administration of some medications as well 
as patients’ attitudes and doctor/patients interaction. This study evaluates the 
influence of the following variables in the adherence of people with diabetes: 
Dosage, patient age, gender, substance, price of drug, pack size, pack strength 
and doctor specialty. Methods: Adherence was calculated using the medical 
possession ratio (MPR) = unique days of therapy/available days. A logistic regres-
sion was conducted to explore the multiple variables affecting the MPR. Results: 
The analyses included 25 months (from July 2009 to July 2011) of longitudinal 
prescription data for Germany for the ATC class A10 (oral antidiabetic). We found 
significant effects on adherence for age groups 55-64 (0.0909 p< 0.01), 65-74 (0.1266, 
p< 0.0004) and > 75 (0.0868, p< 0.0155), dosage (-0.7646, p< 0.0001), gender (-0.0493 
p< 0.001), pack size (0.0119, p < 0.0001), doctor specialty (0.0251, p< 0.0286) and 78% 
of all substances. ConClusions: Adherence seems to be negatively influence 
by dosage and younger age groups. Price does not seem to have an influence. 
Perhaps this is because the health care system in Germany reimbursed all oral 
antidiabetics. Metformin has the greater odds for poor adherence aside from the 
substances “glitazones”. Lower adherence rate might be negatively influenced 
by the recent warnings for Glitazones. Gender is a weak predictor for adherence. 
When comparing specialists with general practitioners, the odds of adherence are 
not very different between them (slightly positive towards the specialist group_ 
coeff 0.0251, p< 0.0286). This could be related to the diabetes management plan 
that exists in Germany since 2003, which has several aspects, from support to 
clinicians to training of patients.
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objeCtives: Diabetes is a chronic illness and 15% of diabetic will develop foot 
ulceration at some point of their life. Poor psychosocial states have been identi-
fied as one of the major risk factors for foot ulcers. Good, regular foot care, strict 
metabolic control and better adjustment to illness can prevent or reduce suffering 
effect of the illness. The purpose of this study was to compare the psychosocial 
adjustment to illness between diabetic patients with and without diabetic foot ulcer 
(DFU). Methods: A case-control study was conducted in a tertiary care teaching 
hospital in South India for a period of one year. Psychosocial Adjustment to Illness 
Scale-Self Report ( PAIS-SR) were used to assess psychosocial adjustment to illness. 
DFU patients (Case) who admitted in the surgery units were included. Diabetic 
patients without foot ulcers (control) were selected from medicine units during the 
same period. Results: The study participants were 84 people with diabetic foot 
ulceration and 84 people without diabetic foot ulceration. There were no significant 
differences between the two groups for gender, age and marital status. A significant 
difference was found between two groups for education level (p= 0.001) occupational 
status (p= 0.045). A significant difference was found between the groups in relation 
to smoking (p= 0.000) and drinking (p= 0.000). There were a significant difference 
seen in PAISSR scores ( lower scores means better adjustments) between the two 
groups (p= 0.000) representing subjects without DFU had better psychosocial adjust-
ment than subjects with DFU. ConClusions: The study concluded that compared 
to patients without DFU, patients with diabetic foot ulcer had poorer metabolic 
control, low educational level, bad social habits. Longer duration of diabetes, longer 
period of hospitalization, low level of disease knowledge and more incidence of 
comorbid conditions.
PDB81
DiminishinG marGinal Disutility of hyPoGlyCaemiC events
Lauridsen J.T.1, Lønborg J.2, Gundgaard J.3, Jensen H.H.2
1Centre of Health Economics Research (COHERE), Department of Business and Economics, 
University of Southern Denmark, Odense, Denmark, 2Incentive Partners, Holte, Denmark, 3Novo 
Nordisk A/S, Søborg, Denmark
objeCtives: Hypoglycaemic events are proven to have a negative impact on 
the health-related quality of life (HRQoL) of patients with diabetes. The negative 
impact of hypoglycaemia on HRQoL may be evaluated via disutility scores. The 
aim of this study was to assess the marginal impact of non-severe hypoglycaemic 
events on HRQoL and to investigate the functional form of the disutility of hypo-
glycaemic events. Methods: Published disutility values from a large-scale, web-
based time-trade-off study (TTO) conducted in UK, USA, Canada, Germany and 
Sweden with 8,286 respondents, were used as a basis for the analysis of non-severe 
